Best pharmaceutical companies in Frederick, MD

AstraZeneca is one of the world's leading pharmaceutical companies. It focuses on the discovery, development and commercialisation of prescription medicines. Its purpose is to deliver life-changing medicines by pushing the boundaries of science. AstraZenesa specializes in three main therapy areas Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory. The company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Its headquarters in North America are located in Wilmington, DE, with additional locations in Gaithersburg, MD, and Boston, MA.

Precision for Medicine is dedicated to supporting the unprecedented acceleration in medical research and the explosion of biomarker and translational sciences. These dynamically changing fields require novel services and an integration of expertise not commonly found in traditional research organizations. We've assembled an extraordinary array of talent and services to enable our pharmaceutical and life sciences clients to take advantage of new advancements in science and stay ahead of regulatory changes. Our team encompasses scientists, clinical trial experts and technical specialists that support our trailblazing clients through: *A state-of-the-art biorepository and laboratory *Biomarker identification through analysis of 'omics and clinical data *A comprehensive approach to companion diagnostic product development *Fully integrated and global clinical trial capabilities

Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services

At Precision Medicine Group, we deliver specialty services that help our life science clients navigate these challenges. For research and development, we bring highly specialized biomarker, laboratory, and clinical trial services as well as the regulatory expertise to manage the precision development pathway. To address commercial excellence, we bring a uniquely specialized set of services that integrate the generation and communication of the evidence necessary to establish value, optimize access, and drive demand. These include integrated market access, advanced payer analytics, health economics, and marketing communications.

Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company's proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala's formulations achieve high, sustained local drug concentrations with reduced systemic exposure and are delivered in a patient friendly format. The company's research efforts have demonstrated successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept, while establishing R&D collaborations with select partners to improve products in their pipelines.

We provide TMS therapy, a non-drug, FDA-cleared #Depression & #OCD treatment. Take our quiz to see if #TMStherapy could be right for you: https://t.co/QNvCqWRdQz

Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.

40 years of experience providing state of the art care to Maryland. We maintain a waiting time averaging less than 20 minutes. Welcome to our site.